8-K: American Public Education Reports Strong 2025 Results

American Public Education, Inc. reported strong financial and operational results for the fourth quarter and full year ended December 31, 2025, with significant revenue and adjusted EBITDA growth for the full year.

Summary

• Full year 2025 consolidated revenue increased 3.9% year-over-year to $648.9 million.
• Full year 2025 adjusted EBITDA increased 18.6% year-over-year to $85.7 million.
• Full year 2025 net income available to common stockholders increased 151.6% to $25.3 million.
• Full year 2025 diluted earnings per share increased 147.3% to $1.36.
• Fourth quarter 2025 consolidated revenue decreased 3.5% year-over-year to $158.3 million, impacted by the federal government shutdown and the sale of Graduate School USA (GSUSA).
• Fourth quarter 2025 net income available to common stockholders increased 9.6% to $12.6 million.
• Fourth quarter 2025 adjusted EBITDA decreased 8.6% to $28.7 million, impacted by the government shutdown.
• Rasmussen University (RU) segment revenue grew 15.9% in Q4 2025 and 13.9% in FY 2025, driven by increased enrollments.
• Hondros College of Nursing (HCN) segment revenue grew 9.5% in Q4 2025 and 11.4% in FY 2025, driven by increased enrollments.
• American Public University System (APUS) segment revenue decreased 13.8% in Q4 2025, primarily due to the government shutdown.
• Cash flows from operations increased 26.8% to $62.0 million for the full year 2025.
• Completed a debt refinancing on March 9, 2026, reducing the borrowing rate by 375 basis points, expected to generate approximately $3.7 million in annual interest expense savings.
• The Board of Directors authorized a common stock repurchase program of up to $50 million on March 10, 2026, replacing prior authorizations.
• The Department of Education lifted both the Letter of Credit and growth restrictions that had prevented Rasmussen University from opening new campuses and adding new programs for the past six years.
• Simplified and strengthened operations by redeeming preferred equity and selling corporate buildings and Graduate School USA in July 2025.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive report, driven by significant full-year financial improvements, strategic divestitures, and the lifting of key regulatory restrictions on Rasmussen University, which should enable future growth.

Positives

• Full Year 2025 Consolidated revenue increased 3.9% to $648.9 million.
• Full Year 2025 Adjusted EBITDA increased 18.6% to $85.7 million.
• Full Year 2025 Net income available to common stockholders increased 151.6% to $25.3 million.
• Full Year 2025 Diluted EPS increased 147.3% to $1.36.
• Rasmussen University (RU) segment revenue grew 15.9% in Q4 2025 and 13.9% in FY 2025, primarily driven by increased enrollments.
• Hondros College of Nursing (HCN) segment revenue grew 9.5% in Q4 2025 and 11.4% in FY 2025, primarily driven by increased enrollments.
• Cash flows from operations increased 26.8% to $62.0 million in FY 2025.
• Successful debt refinancing reduced the borrowing rate by 375 basis points, expected to save approximately $3.7 million annually in interest expense.
• The Board authorized a new $50 million common stock repurchase program.
• The Department of Education lifted the Letter of Credit and growth restrictions on Rasmussen University, allowing new campuses and programs.
• Simplified and strengthened operations by redeeming preferred equity and selling non-core assets (corporate buildings and Graduate School USA).

Negatives

• Fourth Quarter 2025 Consolidated revenue decreased 3.5% to $158.3 million, primarily due to the federal government shutdown and the sale of GSUSA.
• Fourth Quarter 2025 Adjusted EBITDA decreased 8.6% to $28.7 million, impacted by the government shutdown.
• American Public University System (APUS) segment revenue decreased 13.8% in Q4 2025, primarily due to the government shutdown.
• APUS Net Course Registrations decreased 15.3% in Q4 2025 to 82,200.

Risks

• Failure to comply with regulatory and accrediting agency requirements, including the '90/10 Rule', and to maintain institutional accreditation.
• Changes in the post-secondary education regulatory environment as a result of U.S. federal elections or actions of the current administration to the Department of Education.
• Potential or actual government shutdowns, including the U.S. federal government shutdown in the fourth quarter of 2025, and the inability to mitigate these impacts.
• Government budget and federal workforce uncertainty.
• Dependence on the effectiveness of the ability to attract students who persist in institutions' programs.
• Changing market demands and declines in enrollments at subsidiaries.
• Inability to effectively market institutions' programs.
• Inability to maintain strong relationships with the military and maintain course registrations and enrollments from military students.
• Loss or disruption of the ability to receive funds under Title IV or TA programs or the reduction, elimination, or suspension of federal funds.
• Adverse effects of changes made to improve the student experience and enhance the ability to identify and enroll students who are likely to succeed.
• Need to successfully adjust to future market demands by updating existing programs and developing new programs.
• Loss of eligibility to participate in Title IV programs or ability to process Title IV financial aid.
• Economic and market conditions and changes in interest rates.
• Difficulties involving acquisitions.
• Indebtedness, including the refinancing thereof.
• Dependence on and the need to continue to invest in technology infrastructure, including with respect to third-party vendors.
• The inability to recognize the intended benefits of cost savings and reduction and revenue generating efforts.
• Ability to manage and limit exposure to bad debt.
• Various risks described in the 'Risk Factors' section of the Annual Report on Form 10-K for the year ended December 31, 2024, and 2025.

Future Outlook

American Public Education provides Q1 2026 guidance with expected revenue between $173.0 million and $175.0 million, net income of $11.1 million to $12.2 million, adjusted EBITDA of $25.5 million to $27.0 million, and diluted EPS of $0.58 to $0.64. For the full year 2026, the company anticipates revenue of $685.0 million to $695.0 million, net income of $41.3 million to $47.6 million, adjusted EBITDA of $91.5 million to $100.5 million, and diluted EPS of $2.15 to $2.47. Capital expenditures are projected to be $28.0 million to $32.0 million for FY 2026.

Management Comments

• "In 2025, we set ambitious financial and operating goals, and I am proud to report that we delivered $649 million or a 3.9% increase in revenue growth, where notably each of our three institutions produced year-over-year revenue growth."
• "We also delivered $86 million or an 18.6% year-over-year improvement in adjusted EBITDA."
• "We simplified and strengthened APEI by redeeming our preferred equity, and by selling corporate buildings and Graduate School USA."
• "Further, the Department of Education lifted both the Letter of Credit and the growth restrictions that had prevented Rasmussen from opening new campuses and adding new programs for the past six years."
• "As we introduce full year 2026 guidance, we remain committed to driving sustained growth, expanding margins, and delivering on our strategic priorities to continue to build long-term shareholder value."

Industry Context

StockSavvy.ai notes that the post-secondary education sector, particularly online and career-focused institutions, faces ongoing regulatory scrutiny and evolving student demands. APEI's strategic moves, such as divesting non-core assets and addressing regulatory restrictions on Rasmussen, position it to adapt to these dynamics. The lifting of growth restrictions for Rasmussen University is a significant positive development, potentially allowing APEI to capitalize on demand in health sciences and nursing education, which are generally resilient segments. The impact of government shutdowns on APUS highlights the vulnerability of institutions heavily reliant on federal funding or military enrollments.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results for direct industry comparison.

Corporate Governance

Stakeholder Impact

• Shareholders: Positive impact due to strong financial performance, increased EPS, debt refinancing savings, and a new share repurchase program.
• Students (Rasmussen University): Positive impact as the lifting of growth restrictions allows for new campuses and programs, potentially expanding educational opportunities.
• Creditors: Positive impact from debt refinancing reducing borrowing rates and potentially improving financial stability.

Next Steps

• Continue driving sustained growth, expanding margins, and delivering on strategic priorities to build long-term shareholder value.
• Planned combination of American Public University System, Rasmussen University, and Hondros College of Nursing into one consolidated institution.

Key Dates

Recommendation

The company delivered robust full-year 2025 financial results, significantly exceeding prior year performance in revenue, adjusted EBITDA, net income, and EPS. Strategic actions like the sale of GSUSA and redemption of preferred equity have simplified the business. Crucially, the Department of Education lifted long-standing growth restrictions on Rasmussen University, unlocking significant future expansion potential in high-demand nursing and health sciences programs. The debt refinancing will reduce interest expenses, and the new $50 million share repurchase program signals strong management confidence and commitment to shareholder value. The positive outlook for 2026 further reinforces a strong buy recommendation.

Keywords

American Public Education, APEI, Financial Results, Earnings, Higher Education, Online Education, Rasmussen University, Hondros College of Nursing, APUS, SEC Filing, 8-K, Adjusted EBITDA, Revenue Growth, Share Repurchase, Debt Refinancing, Enrollment, Government Shutdown, Regulatory Compliance